Efficacy of long-term treatment with thalidomide in children and young adults with Crohn disease: Preliminary results

Journal of Pediatric Gastroenterology and Nutrition

Volumn 32, Issue 2, 2001, Pages 178-181

  Facchini, Sergio ^a   Candusso, Manila ^a   Martelossi, Stefano ^a   Liubich, Mario ^a   Panfili, Elisabetta ^a   Ventura, Alessandro ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Inflammatory bowel disease; Thalidomide; TNF

Indexed keywords

CYTOKINE; STEROID; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CROHN DISEASE; CYTOKINE RELEASE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LONG TERM CARE; MALE; PARESTHESIA; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CROHN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RECURRENCE; REMISSION INDUCTION; SAFETY; THALIDOMIDE; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035071241     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200102000-00016     Document Type: Article

References (18)

1. Tumor necrosis factor and Crohn disease
2. Tumor necrosis factor a in the stools as a marker of intestinal inflammation
3. Randomised controlled trial of CDP571 antibody to tumor necrosis factor in Crohn disease
4. A multicentre trial of anti-tumor necrosis factor antibody (cA2) for treatment of patients with active Crohn disease
5. Thalidomide as an anti-TNF α inhibitor: Implications for clinical use
6. Thalidomide for the treatment of oral aphtous ulcers in patients with human immunodeficency virus infection
7. Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mRNA degradation
8. Thalidomide in Crohn disease
9. Treatment of ulcerative colitis with thalidomide
10. TNFalpha and response of treatment-resistant adult-onset still's disease to thalidomide
11. Efficacy of thalidomide in the treatment of refractory ankylosing spondilitis
12. An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn disease
13. Thalidomide therapy for patients with refractory Crohn disease: An open-label trial
14. Development and validation of a Paediatric Crohn Disease Activity Index
15. The O.M.G.E. multinational inflammatory bowel disease survey 1976-1982. A further report on 2,657 cases
16. Inhibitors of tumor necrosis factor for rheumatoid arthritis
17. Thalidomide for the treatment of oral aphthous ulcers in Crohn disease
18. Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients